Islet cell adenomatosis
MONDO:0007834A sporadic or inherited disorder characterized by the focal or diffuse proliferation of the cells of the islets of Langerhans in the pancreas. It results in hyperinsulinemia and hypoglycemia.
Also known as: islet cell adenomatosis, INSDM, INSULINOMATOSIS and diabetes mellitus, Insulinomatosis and diabetes mellitus, nesidioblastosis
2 clinical trials for this condition and its sub-types, 0 tagged with Islet cell adenomatosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Islet cell adenomatosis
-
Congenital isolated hyperinsulinism 0 trials · 2 incl. sub-types
4 sub-types
- Diazoxide-sensitive diffuse hyperinsulinism 0 trials · 2 incl. sub-types Sub-types →
- Hyperinsulinemic hypoglycemia, familial, 2 1 trial Sub-types →
- Diazoxide-resistant hyperinsulinism 0 trials Sub-types →
- Hyperinsulinemic hypoglycemia, familial, 3 0 trials
Most studied deeper sub-types
Exercise-induced hyperinsulinism
(1)
Hyperinsulinism-hyperammonemia syndrome
(1)
Autosomal dominant hyperinsulinism due to Kir6.2 deficiency
(0)
Autosomal dominant hyperinsulinism due to SUR1 deficiency
(0)
Autosomal recessive hyperinsulinism due to Kir6.2 deficiency
(0)
Autosomal recessive hyperinsulinism due to SUR1 deficiency
(0)
Diazoxide-resistant diffuse hyperinsulinism
(0)
Diazoxide-resistant focal hyperinsulinism
(0)
Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency
(0)
Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency
(0)
Hyperinsulinemic hypoglycemia, familial, 4
(0)
Hyperinsulinism due to HNF1A deficiency
(0)
Hyperinsulinism due to HNF4A deficiency
(0)
Hyperinsulinism due to UCP2 deficiency
(0)